Holen Sie sich die Stockscreener-App
335.94
0.99%
-3.36
Handel nachbörslich:
335.94
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen Named One of Newsweek’s Most Trustworthy Companies in America 2026 - Amgen
Amgen's Growth Engine Is Just Getting Started (NASDAQ:AMGN) - Seeking Alpha
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits? - TradingView
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Assessing Amgen (AMGN) Valuation After Japan Safety Concerns Over Rare Disease Drug - simplywall.st
Fisher Asset Management LLC Purchases 118,273 Shares of Amgen Inc. $AMGN - MarketBeat
My Personal Plan to Turn Market Chaos Into 300%+ Growth - Investing.com
Allstate Corp Has $13.13 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock (US0311621009): CFO retirement and earnings strength keep focus on guidance - AD HOC NEWS
Mita Ganatra Joins Amgen India as Executive Director, Finance - hrtoday.in
Amgen (AMGN) Announces Retirement of CFO Peter Griffith - Insider Monkey
Wealthquest Corp Acquires Shares of 3,374 Amgen Inc. $AMGN - MarketBeat
Legal & General Group Plc Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by New Age Alpha Advisors LLC - MarketBeat
Simplify Asset Management Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (AMGN) Stock Analysis: Strong ROE and Promising Outlook in the Healthcare Sector - DirectorsTalk Interviews
Amgen Inc. $AMGN Shares Sold by Swedbank AB - MarketBeat
Amgen Inc. $AMGN is Smead Capital Management Inc.'s 5th Largest Position - MarketBeat
Amgen stock (US0311621009): Shares edge lower after early-February trade update - AD HOC NEWS
Amgen stock (US0311621009): earnings beat and leadership change put biotech giant in focus - AD HOC NEWS
Does Amgen’s CFO Transition and Board Structure Shape a New Governance Story for AMGN? - simplywall.st
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Legato Capital Management LLC Acquires Shares of 8,328 Amgen Inc. $AMGN - MarketBeat
Axxcess Wealth Management LLC Raises Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Americana Partners LLC - MarketBeat
Amgen Inc. stock (US0311621009): weight-loss data and obesity ambitions move into focus - AD HOC NEWS
Amgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Amgen Inc. (NASDAQ: AMGN) Stock Trades Near $330 as Japan Drug Safety Crisis Raises Concerns - foreignpolicyjournal.com
Amgen Inc. stock (US0311621009): obesity data, Horizon deal and pipeline put focus back on the biote - AD HOC NEWS
Keudell Morrison Wealth Management Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Rx Rundown: Parabilis Medicines, Boston Scientific, Amgen and more - Medical Marketing and Media
Global Retirement Partners LLC Purchases 5,691 Shares of Amgen Inc. $AMGN - MarketBeat
AMGN Stock Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
A Look At Amgen (AMGN) Valuation As Tavneos Safety Concerns And Withdrawal Requests Escalate - Yahoo Finance
Amgen Inc. Stock 12‑Month Price Target Cut to $352.32, Implies 4% Upside - TradingView
Amgen stock (US0311621009): Q1 revenue tops estimates, CFO change keeps debt in focus - AD HOC NEWS
Amgen (AMGN) director Amy E. Miles awarded 665 RSUs, now holds 5,640 shares - Stock Titan
Amgen (AMGN) director Ellen Kullman receives 665-share RSU equity grant - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665 RSUs in stock award - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665-share equity award, now holds 18,284 - Stock Titan
Amgen Shareholders Reaffirm Board, Pay and Auditors - The Globe and Mail
Amgen (AMGN) director Omar Ishrak receives 665-share stock grant in Form 4 - Stock Titan
Amgen (AMGN) director Charles Holley receives 665-share RSU grant and reports 12.8K direct holdings - Stock Titan
Amgen (AMGN) director Garland receives 665 RSUs that vest immediately - Stock Titan
Amgen (AMGN) director receives 665 RSUs in immediate stock grant - Stock Titan
Amgen (NASDAQ: AMGN) director Brian Druker receives 665-share RSU grant - Stock Titan
Amgen (AMGN) director Michael V. Drake receives 665-share RSU award - Stock Titan
Amgen (AMGN) director receives 665-share RSU stock grant award - Stock Titan
Amgen’s ‘boomerang’ CFO reaps $12.5M in cash, retention bonuses - CFO Dive
Amgen Wants To Preserve Right To Seek Double Tax Relief - Law360
Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline - simplywall.st
Amgen Drug Gets New Warnings in Japan After Patient Deaths - WSJ
Amgen's Q1 earnings top estimates, 16 drugs deliver double-digit gains - MSN
The Escalator: Amgen, CG Life, Cosette Pharmaceuticals and more - Medical Marketing and Media
IFP Advisors Inc Has $3.92 Million Stake in Amgen Inc. $AMGN - MarketBeat
Liquidity Mapping Around (AMGN) Price Events - Stock Traders Daily
Amgen Inc. (AMGN): Navellier’s Long-Term Pick on Pipeline Strength and Sales Growth - Insider Monkey
ABN Amro Investment Solutions Acquires 13,431 Shares of Amgen Inc. $AMGN - MarketBeat
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen's CFO resigns – a successor has been named - medwatch.com
Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Amgen Inc. 8-K Filing May 2026: Executive Compensation Approval and Shareholder Voting Results - Minichart
Declaration of Voting Results by Amgen Inc - marketscreener.com
Amgen (NASDAQ: AMGN) investors reject independent chair proposal - Stock Titan
As Griffith retires, Dittrich returns to Amgen, takes CFO role - biocentury.com
The Story of Maridebart Cafraglutide (MariTide) - Amgen
Amgen’s Approach to AI-Enabled Clinical Development - Amgen
Amgen : Approach to AI-Enabled Clinical Development - marketscreener.com
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer - TipRanks
Amgen Inc. stock (US0311621009): Weight-loss drug data and guidance update keep investors on alert - AD HOC NEWS
1.71%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):